Abstract:
A conveying apparatus for conveying an object, the object having at least a non-opaque portion, including a light source, an optical detector and a backing measurement apparatus, the light source for illuminating the object, the optical detector for acquiring information at least relating to at least one chromatic characteristic of the non-opaque portion, the backing measurement apparatus including a backing material, a backing support and a plurality of rollers, the backing material exhibiting at least one of determined chromatic characteristics and determined optical characteristics, the backing support for supporting the backing material, the plurality of rollers for rolling the backing material over the backing support, wherein light emitted by the light source optically interacts with the backing material consistently through the non-opaque portion.
Abstract:
Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
Abstract:
The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Abstract:
The present invention provides compounds of Formula (I), including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Abstract:
The invention provides a type of lithium-ion battery cathode materials applicable to a high charge cut-off voltage. The cathode materials comprises two active substances of LiCoO2 and Li (NixCoyMn1-x-y)O2, where 0.3≦x≦0.8, 0.1≦y≦0.4, and 0.6≦x+y≦0.9. Both LiCoO2 and Li(NixCoyMn1-x-y)O2 are doped with element M and then treated by surface coating with the oxide, sulfide, fluoride of element M′ or phosphate. The element M is at least one of the Mg, Ti, Al, Zr, B, La, Ce, Y, P, S, N or F while the element M′ is at least one of the Al, Ti, Mg, Zr, B, Si, Fe, La, Ce or Y. The cathode materials provided herein, having the advantages of excellent cycling performance and low cell swelling against high temperature, can help to remarkably increase the energy density of lithium-ion batteries. The invention also discloses a lithium-ion battery containing such cathode materials.
Abstract translation:本发明提供一种适用于高电荷截止电压的锂离子电池正极材料。 阴极材料包含两种LiCoO2和Li(NixCoyMn1-x-y)O2的活性物质,其中0.3 @ x @ 0.8,0.1 @ y @ 0.4和0.6 @ x + y @ 0.9。 LiCoO2和Li(NixCoyMn1-x-y)O2都掺杂有元素M,然后用元素M'或磷酸盐的氧化物,硫化物,氟化物进行表面涂覆处理。 元素M是Mg,Ti,Al,Zr,B,La,Ce,Y,P,S,N或F中的至少一种,而元素M'是Al,Ti,Mg,Zr中的至少一种 ,B,Si,Fe,La,Ce或Y.本文提供的具有优异的循环性能和低温度的低电池膨胀的优点的阴极材料有助于显着增加锂离子电池的能量密度。 本发明还公开了一种含有这种阴极材料的锂离子电池。
Abstract:
A conveying apparatus for conveying an object, the object having at least a non-opaque portion, including a light source, an optical detector and a backing measurement apparatus, the light source for illuminating the object, the optical detector for acquiring information at least relating to at least one chromatic characteristic of the non-opaque portion, the backing measurement apparatus including a backing material, a backing support and a plurality of rollers, the backing material exhibiting at least one of determined chromatic characteristics and determined optical characteristics, the backing support for supporting the backing material, the plurality of rollers for rolling the backing material over the backing support, wherein light emitted by the light source optically interacts with the backing material consistently through the non-opaque portion.
Abstract:
Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. Formula (I).
Abstract:
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I): Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Abstract:
A method, a system and an apparatus for synchronizing the stream between the bearer control layer and bearer layer devices. Bearer layer device returns information corresponding to the stream synchronizing information distributed by the resource manager RM of the bearer control layer back to the resource manager RM (101, 102); when the resource manager RM determines that there is information needed to be synchronized included in the information returned by bearer layer device (103), it compares the information with the one held by itself (105), and performs synchronization to the information within the bearer layer devices that need to be synchronized according to the result of the comparison.
Abstract:
Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. Formula (I).